Cargando…

Enhanced Chemosensitivity by Targeting Nanog in Head and Neck Squamous Cell Carcinomas

Chemo-resistance is the major cause of high mortality in head and neck squamous cell carcinomas (HNSCC) in which HNSCC-derived cancer stem cells (CSCs) may be involved. Previously, we enriched a subpopulation of HNSCC-derived spheroid cells (SC) (HNSCC-SC) and identified Nanog as a CSCs marker. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chuan-En, Yu, Cheng-Chia, Hu, Fang-Wei, Chou, Ming-Yung, Tsai, Lo-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200775/ https://www.ncbi.nlm.nih.gov/pubmed/25158233 http://dx.doi.org/10.3390/ijms150914935

Ejemplares similares

Concurrent Expression of Oct4 and Nanog Maintains Mesenchymal Stem-Like Property of Human Dental Pulp Cells
por: Huang, Chuan-En, et al.
Publicado: (2014)

Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas
por: Pedregal-Mallo, Daniel, et al.
Publicado: (2020)

Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma
por: Yamashita, Taku, et al.
Publicado: (2016)

Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma
por: Habu, Noboru, et al.
Publicado: (2015)

The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines
por: Schnoell, Julia, et al.
Publicado: (2023)

Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma
por: Chou, Ming-Huei, et al.
Publicado: (2021)

MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma
por: Chen, Li-Hsin, et al.
Publicado: (2010)

ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas
por: Huang, Chuang, et al.
Publicado: (2020)

In vitro chemosensitivity of head and neck cancer cell lines
por: Schuler, PJ, et al.
Publicado: (2010)

Pescadillo ribosomal biogenesis factor 1 reduction suppresses tumour growth and renders chemosensitivity of head and neck squamous cell carcinoma
por: Li, Dapeng, et al.
Publicado: (2022)

The pluripotency factor NANOG promotes the formation of squamous cell carcinomas
por: Palla, Adelaida R., et al.
Publicado: (2015)

Expression of NANOG and Its Regulation in Oral Squamous Cell Carcinoma
por: Grubelnik, Gašper, et al.
Publicado: (2020)

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
por: Chen, Jin‐Hua, et al.
Publicado: (2016)

TALEN-mediated Nanog disruption results in less invasiveness, more chemosensitivity and reversal of EMT in Hela cells
por: Ding, Yan, et al.
Publicado: (2014)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Targeting M-MDSCs enhances the therapeutic effect of BNCT in the 4-NQO-induced murine head and neck squamous cell carcinoma model
por: Chang, Chun-Hsiang, et al.
Publicado: (2023)

Mammalian target of rapamycin and head and neck squamous cell carcinoma
por: Liao, Yu-Min, et al.
Publicado: (2011)

An update on angiogenesis targeting in head and neck squamous cell carcinoma
por: Micaily, Ida, et al.
Publicado: (2020)

Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
por: Liu, Shuo, et al.
Publicado: (2022)

Targeted therapy for head and neck squamous cell carcinoma microenvironment
por: Guo, Zhaomeng, et al.
Publicado: (2023)

Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas
por: Hsu, Cheng-Ming, et al.
Publicado: (2021)

6-shogaol is a potential treatment for Head and Neck Squamous Cell Carcinoma
por: Hsu, Cheng-Ming, et al.
Publicado: (2023)

Distinct population of highly malignant cells in a head and neck squamous cell carcinoma cell line established by xenograft model
por: Chen, Chi-Yuan, et al.
Publicado: (2009)

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
por: Reuter, C W M, et al.
Publicado: (2007)

Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib
por: Gandhi, Mitul D, et al.
Publicado: (2014)

Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma
por: Wu, Yaping, et al.
Publicado: (2019)

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Wang, Hui-Ching, et al.
Publicado: (2019)

Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma
por: Kordbacheh, Farzaneh, et al.
Publicado: (2021)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Pparg may Promote Chemosensitivity of Hypopharyngeal Squamous Cell Carcinoma
por: Lian, Meng, et al.
Publicado: (2020)

Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma
por: Wu, Zeng-Hong, et al.
Publicado: (2020)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Predictive Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma
por: Chen, Miao-Fen, et al.
Publicado: (2018)

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
por: KjellÃ©n, E., et al.
Publicado: (1989)

Stem Cell Marker (Nanog) and Stat-3 Signaling Promote MicroRNA-21 Expression and Chemoresistance in Hyaluronan/CD44-activated Head and Neck Squamous Cell Carcinoma Cells
por: Bourguignon, Lilly Y. W., et al.
Publicado: (2011)

Targeting claudin‐4 enhances chemosensitivity of pancreatic ductal carcinomas
por: Sasaki, Takamitsu, et al.
Publicado: (2019)

Identification of potential therapeutic targets in human head & neck squamous cell carcinoma
por: Han, Jing, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_to1de7fg1snnqgdq07kc0o33ca